raloxifene has been researched along with Angiogenesis, Pathologic in 1 studies
raloxifene : A member of the class of 1-benzothiophenes that is 1-benzothiophene in which the hydrogens at positions 2, 3, and 6 have been replaced by p-hydroxyphenyl, p-[2-(piperidin-1-yl)ethoxy]benzoyl, and hydroxy groups, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luo, G | 1 |
| Tang, Z | 1 |
| Lao, K | 1 |
| Li, X | 1 |
| You, Q | 1 |
| Xiang, H | 1 |
1 other study available for raloxifene and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Structure-activity relationships of 2, 4-disubstituted pyrimidines as dual ERĪ±/VEGFR-2 ligands with anti-breast cancer activity.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Dose-Response Relationship, Drug; Drug | 2018 |